Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$1.59B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.04B |
| 3 |
Microsoft
MSFT
|
+$794M |
| 4 |
Home Depot
HD
|
+$512M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
+$357M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$491M |
| 2 |
Linde
LIN
|
+$373M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$298M |
| 4 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$290M |
| 5 |
Salesforce
CRM
|
+$249M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.37% |
| 2 | Healthcare | 7.45% |
| 3 | Consumer Discretionary | 5.14% |
| 4 | Industrials | 5.1% |
| 5 | Financials | 4.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
iRadimed
IRMD
$1.16B
| $2.64M | ﹤0.01% |
55,303
+9,469
| +21% | +$427K |
|
3177
Ardagh Metal Packaging
AMBP
$2.83B
| $2.64M | ﹤0.01% |
702,069
+548,540
| +357% | +$2.03M |
|
|
INST
3178
DELISTED
Instructure Holdings, Inc.
INST
| $2.64M | ﹤0.01% |
104,829
+16,833
| +19% | +$422K |
|
3179
CALL
Waste Management
WM
$90.6B
| $2.64M | ﹤0.01% |
15,200
-22,600
| -60% | -$3.74M |
|
3180
Stanley Black & Decker
SWK
$14.3B
| $2.63M | ﹤0.01% |
28,107
+4,026
| +17% | +$333K |
|
3181
Toyota
TM
$224B
| $2.63M | ﹤0.01% |
16,368
-7,940
| -33% | -$1.14M |
|
3182
Alkami Technology
ALKT
$1.94B
| $2.63M | ﹤0.01% |
160,453
+103,248
| +180% | +$1.42M |
|
|
DRD
3183
DRDGold
DRD
$1.77B
| $2.63M | ﹤0.01% |
247,583
+106,384
| +75% | +$1.21M |
|
3184
Werewolf Therapeutics
HOWL
$17.2M
| $2.62M | ﹤0.01% |
859,247
-238,101
| -22% | -$670K |
|
3185
Hope Bancorp
HOPE
$1.79B
| $2.61M | ﹤0.01% |
310,538
+32,121
| +12% | +$280K |
|
|
CNDA
3186
DELISTED
Concord Acquisition Corp II
CNDA
| $2.6M | ﹤0.01% |
253,739
| – | – |
|
|
FIRY
3187
Firy Inc
FIRY
$148M
| $2.6M | ﹤0.01% |
285,470
+192,136
| +206% | +$2.22M |
|
3188
Global X Copper Miners ETF NEW
COPX
$7.29B
| $2.6M | ﹤0.01% |
+68,968
| New | +$2.65M |
|
3189
CALL
uniQure
QURE
$3.03B
| $2.59M | ﹤0.01% |
+226,200
| New | +$4.29M |
|
3190
BlackBerry
BB
$4.98B
| $2.59M | ﹤0.01% |
+467,054
| New | +$2.26M |
|
3191
OptimizeRx
OPRX
$114M
| $2.58M | ﹤0.01% |
180,800
-149,563
| -45% | -$2.13M |
|
3192
NewMarket
NEU
$7.82B
| $2.57M | ﹤0.01% |
6,403
-6,120
| -49% | -$2.39M |
|
3193
Perella Weinberg Partners
PWP
$1.29B
| $2.57M | ﹤0.01% |
308,742
+158,249
| +105% | +$1.31M |
|
3194
Nektar Therapeutics
NKTR
$2.39B
| $2.57M | ﹤0.01% |
298,055
+294,305
| +7,848% | +$3.14M |
|
3195
CALL
Futu Holdings
FUTU
$14.7B
| $2.57M | ﹤0.01% |
+64,700
| New | +$2.75M |
|
3196
Direxion Daily S&P 500 Bull 3x ETF
SPXL
$6.72B
| $2.57M | ﹤0.01% |
+28,575
| New | +$2.22M |
|
3197
PUT
Macy's
M
$6.53B
| $2.57M | ﹤0.01% |
160,100
-664,900
| -81% | -$10.6M |
|
3198
Verizon
VZ
$195B
| $2.57M | ﹤0.01% |
69,064
-2,665,999
| -97% | -$98.7M |
|
3199
Evotec
EVO
$679M
| $2.56M | ﹤0.01% |
228,954
-5,669
| -2% | -$60.5K |
|
3200
Ultragenyx Pharmaceutical
RARE
$2.45B
| $2.56M | ﹤0.01% |
55,445
-706,402
| -93% | -$32.8M |
|
Similar funds
Millennium Management's Q2 2023 Portfolio in Review
As of Q2 2023, Millennium Management held 7,181 positions worth $203B, up 16% from $174B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Millennium Management deployed $14B of net new capital in Q2 2023, opening 869 new positions and adding to 2,214 existing holdings. Its largest new stake was ResMed: 632,015 shares worth $138M.
By sector, the portfolio is most concentrated in Technology at 8.4% of assets, up from 8.4% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Tesla, an estimated $491M trimmed.
- Millennium Management's largest Q2 2023 buy was ResMed: 632,015 shares worth $138M.
- Millennium Management added most to iShares Core S&P 500 ETF in Q2 2023, an estimated $1.59B increase.
- Millennium Management's biggest Q2 2023 reduction was Tesla, cutting an estimated $491M.
- Millennium Management fully exited Shaw Communications Inc. in Q2 2023, selling an estimated $237M.
- Millennium Management's ten largest holdings make up 26% of its $203B portfolio in Q2 2023.
- Millennium Management opened 869 new positions and closed 1,192 in Q2 2023.
- Millennium Management's portfolio value rose 16% quarter-over-quarter to $203B.
Based on Millennium Management's 13F filing for Q2 2023, filed 14 Aug 2023.